VIV, the NYSE-listed ADR for Telefônica Brasil, approaches its July 27 results with short sellers retreating and the lending market remaining extremely comfortable — a setup that strips away one obvious source of volatility but leaves the analyst debate squarely front and centre.
The borrow market signals very little conviction from the short side. Short interest has fallen roughly 15% over the past month to around 3.9 million shares, and the lending pool remains wide open: availability runs at 538%, meaning more than five shares are available to borrow for every one already lent out. That is well below the tightest reading of the past year (114%) and points to a relaxed, uncrowded borrow market. Cost to borrow, while it has more than doubled over the past month to 1.18%, remains low in absolute terms — easily in the "general collateral" range. The stock itself has slid 2.4% in Thursday's session to $13.70, paring a solid 5.4% monthly gain, suggesting some pre-earnings profit-taking rather than a directional macro call. Options positioning reinforces that reading: the put/call ratio of 1.54 sits fractionally below its 20-day average of 1.56 and is barely a standard deviation from normal, meaning options traders are not paying up for crash protection ahead of the release.
The more live tension for this stock is the analyst picture, and it has shifted bearish at the margin. Barclays lowered its target to $15.50 from $16.50 just eight days ago, maintaining its Equal-Weight rating — a modest trim that still implies roughly 13% upside from current levels. Scotiabank followed a similar pattern through May and June, nudging its target in both directions while holding a neutral Sector Perform stance. The sharpest recent moves came earlier in the year: UBS downgraded to Sell in March and JPMorgan had moved to Underweight in late 2025 — a meaningful pair of negative signals from major institutions that have hung over the stock. Goldman Sachs remains a lone Buy, though its target of $12.60 sits below the current price of $13.70, which is worth noting as a potential data inconsistency given the stock has since rallied. The broader consensus mean target clusters around $15–$16, implying modest room above current levels. Bulls point to the company's dividend credentials — the dividend factor score ranks at the 93rd percentile of the ORTEX universe — and to forward EPS momentum that has turned incrementally positive. Bears flag momentum deterioration: the 182-day relative strength has flipped from deeply positive to mildly negative, and the stock is trading at roughly 75% of its 52-week high, down from 93% at the start of the year.
Earnings history adds a note of caution. The two most recent prints were both followed by sharp negative reactions — the stock fell 3.4% on the day and 6.9% over the following five days after the May 2026 report, with a similar pattern emerging from the preceding quarter. That consistent post-earnings softness has shaped the current positioning: short sellers have stepped back from pressing the short, while institutional holders remain broadly steady, with Telef ónica S.A. anchoring 78% of shares and smaller asset managers including BlackRock and JP Morgan Asset Management making only incremental adjustments.
The July 27 print will test whether the company can deliver results that break the recent pattern of post-earnings drift, or whether the gap between the current price and most analyst targets provides the floor that bulls are counting on.
See the live data behind this article on ORTEX.
Open VIV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
